Santa Cruz Biotechnology

Ro 08-2750 | Santa Cruz Biotechnology

NGFR Inhibitor, Ro 08-2750 is a TrkA inhibitor and NGF-induced apoptosis inhibitor

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.